Zhejiang Hisun Pharmaceutical (600267.SH) releases a forecasted profit, estimating a net profit of 570-630 million yuan in 2024, turning losses into profits.

22/01/2025

GMT Eight

Zhejiang Hisun Pharmaceutical (600267.SH) announced that the company expects to achieve a net profit attributable to shareholders of the listed company of 570 million to 630 million yuan in 2024, compared to a loss in the same period last year.

Shenzhen Increase Technology (300713.SZ) expects a net loss between 74.90 million yuan and 98.97 million yuan for the year.

Yorhe Fluid Intelligent Control (002795.SZ) forecasts a net loss of 210 million to 300 million yuan for the year 2024.

Contact: contact@gmteight.com

Zhejiang Hisun Pharmaceutical (600267.SH) releases a forecasted profit, estimating a net profit of 570-630 million yuan in 2024, turning losses into profits.

RECOMMEND

Guangdong Provincial Expressway Development (000429.SZ) net profit for fiscal year 2024 is 1.562 billion yuan, a year-on-year decrease of 4.39%.

Integrity Technology Group Inc. (688244.SH) is expected to have a pre-reduction, with an estimated annual net profit of 7 to 10 million yuan, a year-on-year decrease of 67.85% to 77.5%.

Shanghai Nar Industrial(002825.SZ) plans to acquire the controlling stake of Lanwei Electronics, further enriching the company's industrial layout.